These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 476621)

  • 21. [In-vitro-technique for autoradiographic investigations of cell proliferation in benign and malignant alterations of the human urinary bladder mucosa from biopsy specimens (author' transl)].
    Dlhos A; Lennartz KJ; Dlhos P; Heising J; Kaiser C; Engelking R
    Urologe A; 1979 Mar; 18(2):112-4. PubMed ID: 433009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder.
    Fossä SD
    Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific binding, stimulation of rodent urinary bladder epithelial ornithine decarboxylase, and induction of transitional cell hyperplasia by the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Ertürk E; Bryan GT
    Cancer Res; 1983 Dec; 43(12 Pt 1):5964-71. PubMed ID: 6315223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal characterization and isoenzyme pattern of non-malignant and malignant human urothelial cell lines.
    Debiec-Rychter M; Christensen B; Kieler J; Wang CY
    Anticancer Res; 1986; 6(5):1237-44. PubMed ID: 3800330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy.
    Langzam L; Koren R; Gal R; Kugel V; Paz A; Farkas A; Sampson SR
    Am J Clin Pathol; 2001 Sep; 116(3):377-85. PubMed ID: 11554166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma.
    Margulies IM; Höyhtyä M; Evans C; Stracke ML; Liotta LA; Stetler-Stevenson WG
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):467-74. PubMed ID: 1302559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cathepsin D in transitional cell bladder tumours.
    Lipponen PK
    J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines].
    Sumi S; Kihara K; Kageyama Y; Higashi Y; Fukui I; Oshima H
    Hinyokika Kiyo; 1990 Aug; 36(8):903-6; Discussion 906-7. PubMed ID: 1700590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Orotate phosphoribosyl transferase in bladder cancer].
    Furuse H; Hirano Y; Harada M; Mugiya S; Ushiyama T; Suzuki K; Ozono S
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1431-3. PubMed ID: 15446572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of two distinct galactosyltransferase activities in populations of mouse peritoneal macrophages.
    Sheares BT; Mercurio AM
    J Immunol; 1987 Dec; 139(11):3748-52. PubMed ID: 3119716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the affinity of phosphotungstic acid and positively charged colloidal particles for the surfaces of malignant human transitional epithelium of the urinary bladder.
    Dermer GB; Kern WH
    Cancer Res; 1974 Aug; 34(8):2011-4. PubMed ID: 4135227
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.
    Buick RN; Stanisic TH; Fry SE; Salmon SE; Trent JM; Krasovich P
    Cancer Res; 1979 Dec; 39(12):5051-6. PubMed ID: 498131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of two cell lines derived from human transitional cell carcinoma.
    Chang J; Sui Z; Ma T; Ma K; Zhang X; Wang J; Dong K; Yao Q
    Chin Med J (Engl); 1995 Jul; 108(7):522-7. PubMed ID: 7555271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of thymidine kinase activity in bladder carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Kamoi K; Miki T
    Cancer; 2002 Nov; 95(10):2120-5. PubMed ID: 12412165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of CA19-9 as a tumor marker in urothelial malignancy.
    Chuang CK; Liao SK
    Scand J Urol Nephrol; 2004; 38(5):359-65. PubMed ID: 15764245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.